about
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making ...
Read More
31.40
-1.29
(-3.95%)
376.1K
XNAS Volume
XNAS 31 Jul, 2025 3:50 PM (EDT)
Board Meeting
The next board meeting for Harrow Health Inc is on 08 Aug 2025 for the purpose of Harrow Inc Second Quarter Earnings Conference Call for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Harrow Health Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..